<DOC>
	<DOCNO>NCT02921152</DOCNO>
	<brief_summary>Operable early stage breast cancer patient stag accord NCCN guideline subject bone marrow aspiration/trephine biopsy time definitive operation general anesthesia . The specimen fixate neutral tamponaded formalin section examine H &amp; E cytokeratin immunohistochemically . If disseminate tumor cell identify ER ( estrogen receptor ) , PR ( progesterone receptor ) , HER2/neu study . Disseminated tumor cell record quantitively semiquantitatively . Results pilot study evaluate observational study .</brief_summary>
	<brief_title>Bone Marrow Micrometastases Patients With Early Stage Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Micrometastasis</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients 18 year old give informed consent enter study . 2 . ASA III patient 3 . Patients diagnose breast cancer receive type treatment regard breast cancer time study 4 . Patients appropriate bone marrow biopsy 5 . Menopausal status relevant . Exclusion criterion : 1 . Active collagen tissue disorder 2 . Patients diagnose breast cancer receive type treatment regard breast cancer time study 3 . Pregnancy 4 . Patients bleed disorder , receive antiaggregant anticoagulant medication . 5 . Patients refuse enter study protocol refuse give inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>